Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
DNA FREE CRISPR PLANT TRANSFORMATION
Document Type and Number:
WIPO Patent Application WO/2019/150200
Kind Code:
A3
Abstract:
Disclosed herein are compositions of transfection enhancing agents, including PLUS reagents, lipofectamine and/or PEG solutions for ribonucleoprotein-mediated delivery of programmable endonucleases to plants and methods of use thereof, such as plant genome engineering.

Inventors:
PARK AIDEN (KR)
PARK SLKI (KR)
YOON JI (KR)
CHOI SUNMEE (KR)
CHOE SUNGHWA (KR)
PARK JONGJIN (KR)
Application Number:
PCT/IB2019/000132
Publication Date:
September 26, 2019
Filing Date:
January 29, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
G FLAS LIFE SCIENCES (KR)
PARK AIDEN Y (KR)
PARK SLKI (KR)
YOON JI YOUNG (KR)
CHOI SUNMEE (KR)
CHOE SUNGHWA (KR)
International Classes:
C12N9/22; C12N15/82; C12N15/10; C12N15/11; C12N15/113
Domestic Patent References:
WO2014204726A12014-12-24
Other References:
WOO, J. W. ET AL.: "DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins", NATURE BIOTECHNOLOGY, vol. 33, no. 11, 2015, pages 1162 - 1164, XP055290196
KIM, K. ET AL.: "Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration", GENOME RESEARCH, vol. 27, no. 3, 2017, pages 419 - 426, XP055636224
KIM, H. ET AL.: "CRISPR/Cpfl-mediated DNA-free plant genome editing", NATURE COMMUNICATIONS, vol. 8, no. 14406, 16 February 2017 (2017-02-16), pages 1 - 7, XP002786577
YU , X. ET AL.: "Improved delivery of Cas9 protein/gRNA complexes using lipofectamine CRISPRMAX", BIOTECHNOLOGY LETTERS, vol. 38, 2016, pages 919 - 929, XP002765623
BURGER, A. ET AL.: "Maximizing mutagenesis with solubilized CRISPR-Cas9 ribonucleoprotein complexes", DEVELOPMENT, vol. 143, no. 11, 2016, pages 2025 - 2037, XP055636227
Download PDF: